18F-FDG PET in liver transplantation setting of hepatocellular carcinoma predicting histology?

Clinical Nuclear Medicine

Volumn 41, Issue 3, 2016, Pages e126-e129

  Bailly, Matthieu ^a,b   Venel, Yann ^b   Orain, Isabelle ^c   Salamé, Ephrem ^d   Ribeiro, Maria Joao ^b  

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^b CHU BRETONNEAU   (France)

^c SERVICE DE DERMATOLOGIE   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

F FDG PET CT; Hepatocellular carcinoma; Tumor differentiation; Vascular invasion

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET-CT SCANNER; PREOPERATIVE EVALUATION; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; TUMOR INVASION; AGED; DIAGNOSTIC IMAGING; EVALUATION STUDY; LIVER TUMOR; MIDDLE AGED; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; TUMOR RECURRENCE; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84946615834     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000001040     Document Type: Article

References (15)

1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
2. Jonas S, Bechstein WO, Steinmüller T, et al. Vascular invasion and histo-pathologic grading determine outcome after liver transplantation for hepa-tocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080-1086.
3. 18F-FDG PETor PET/CT for detecting ex-trahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2012;81:2417-2422.
4. Hiraoka A, Hirooka M, Ochi H, et al. Importance of screening for synchronous malignant neoplasms in patients with hepatocellular carcinoma: impact of FDG PET/CT. Liver Int. 2013;33:1085-1091.
5. 18F-FDG-uptake of hepato-cellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant. 2009;9:592-600.
6. 18F-FDG uptake of hepatocellular carcinoma on positron emission tomography independently predicts tumor recurrence in liver transplant patients. Transplant Proc. 2009;41:2561-2563.
7. 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med. 2009;50:682-687.
8. Yang SH, Suh KS, Lee HW, et al. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl. 2006;12:1655-1660.
9. Lee SD, Kim SH, Kim YK, et al. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma. Transpl Int. 2013;26:50-60.
10. Torizuka T, Tamaki N, Inokuma T, et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med. 1995; 36:1811-1817.
11. Khan MA, Combs CS, Brunt EM, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol. 2000;32:792-797.
12. Olthoff KM, Millis JM, Rosove MH, et al. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg. 1990;125:1261-1266, discussion 1266-1268.
13. Pawlik TM, Gleisner AL, Anders RA, et al. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg. 2007;245:435-442.
14. Petrides AS, DeFronzo RA. Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabetes Metab Rev. 1989;5:691-709.
15. Esnaola NF, Lauwers GY, Mirza NQ, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg. 2002;6:224-232 discussion 232.